Form D · Pharmaceuticals
Groupe Athena, Inc.
Avenel, NJ · CIK 0001486095
Offering snapshot reported Mar 3, 2010 · SEC filing
- Reported sold
- $2.36M Indefinite offering
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 12, 2008 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2010 | Initial | $2,355,000 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-139200
Neither commissions nor finder's fees were paid in connection with this offering.
Source: Form D, filed Mar 3, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Prakash Iyer | Executive |
| Dipika Purhoit | Executive |
| Pooja Rajpurhoit | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
111 Remsen Avenue
Avenel, NJ, 07001
Avenel, NJ, 07001